Key facts
- Notable investors include Lazio Innova.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for GeneS (Laboratory Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for GeneS (Laboratory Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GeneS (Laboratory Services)
Provider of testing and laboratory services intended to support human DNA analysis for health and research purposes. The company offers gut microbiota, vaginal microbiota, oral microbiome, precision medicine, and nutrition analysis to maximize the efficiency of our microbiota for the proper functioning of the immune system and metabolic health, enabling patients to safeguard themselves against various disorders and diseases.
- Sector
- Healthcare
- HQ
- Rome, Italy
- Founded
- 2019
- Employees
- 7
- Website
- genes4you.it/
- Ownership
- Privately Held (backing)
GeneS (Laboratory Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GeneS (Laboratory Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GeneS (Laboratory Services) in its N-PORT filings yet. We sweep new filings monthly.